Journal List > Urogenit Tract Infect > v.14(1) > 1124664

TOOLS
Chung and Jung: Perioperative Risk Factors Related to Systemic Inflammatory Response Syndrome after Percutaneous Nephrolithotomy
Review

Urogenit Tract Infect 2019;14(1):9-13.

Published online: 20 April 2019

DOI: https://doi.org/10.14777/uti.2019.14.1.9

Perioperative Risk Factors Related to Systemic Inflammatory Response Syndrome after Percutaneous Nephrolithotomy

Ho Seok Chung, Seung Il Jung

Department of Urology, Chonnam National University Medical School, Gwangju, Korea

Correspondence to: Seung Il Jung https://orcid.org/0000-0003-4864-8175 Department of Urology, Chonnam National University Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun 58128, Korea Tel: +82-61-379-7749, Fax: +82-61-379-7750 E-mail: drjsi@yahoo.co.kr

Received 1 April 2019       Revised 23 April 2019       Accepted 23 April 2019

Copyright © 2019 Korean Association of Urogenital Tract Infection and Inflammation

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Percutaneous nephrolithotomy (PCNL) has become the standard treatment for large and complex kidney stones since its introduction in 1976. On the other hand, postoperative complications are not rare and can be quite significant. Of these complications, postoperative infectious complications, such as systemic inflammatory response syndrome (SIRS), remain a seminal event and a possible cause of perioperative mortality. Several recent studies have found a number of factors that increase the risk of SIRS after PCNL. These include preoperative factors (patient's characteristics) and factors associated with the intraoperative and postoperative findings. The present study describes the perioperative risk factors of SIRS after PCNL. These findings can help decrease the incidence of infectious complications, including SIRS, in patients undergoing PCNL.

Keywords: Percutaneous nephrolithotomy, Risk factors, Systemic inflammatory response syndrome, Urinary tract infections

References

1. Fernstrom I, Johansson B. Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol. 1976; 10:257–9.
2. de la Rosette J, Assimos D, Desai M, Gutierrez J, Lingeman J, Scarpa R, et al. CROES PCNL Study Group. The Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study: indications, complications, and outcomes in 5803 patients. J Endourol. 2011; 25:11–7.
3. Lai WS, Assimos D. Factors associated with postoperative infection after percutaneous nephrolithotomy. Rev Urol. 2018; 20:7–11.
4. Deshmukh S, Sternberg K, Hernandez N, Eisner BH. Compliance with American Urological Association guidelines for postpercutaneous nephrolithotomy antibiotics does not appear to increase rates of infection. J Urol. 2015; 194:992–6.
crossref
5. Wollin DA, Joyce AD, Gupta M, Wong MYC, Laguna P, Gravas S, et al. Antibiotic use and the prevention and management of infectious complications in stone disease. World J Urol. 2017; 35:1369–79.
crossref
6. Ivan SJ, Sindhwani P. Comparison of guideline recommendations for antimicrobial prophylaxis in urologic procedures: variability, lack of consensus, and contradictions. Int Urol Nephrol. 2018; 50:1923–37.
crossref
7. Chen L, Xu QQ, Li JX, Xiong LL, Wang XF, Huang XB. Systemic inflammatory response syndrome after percutaneous nephrolithotomy: an assessment of risk factors. Int J Urol. 2008; 15:1025–8.
crossref
8. Singh P, Yadav S, Singh A, Saini AK, Kumar R, Seth A, et al. Systemic inflammatory response syndrome following percutaneous nephrolithotomy: assessment of risk factors and their impact on patient outcomes. Urol Int. 2016; 96:207–11.
crossref
9. He Z, Tang F, Lei H, Chen Y, Zeng G. Risk factors for systemic inflammatory response syndrome after percutaneous nephrolithotomy. Prog Urol. 2018; 28:582–7.
crossref
10. Erdil T, Bostanci Y, Ozden E, Atac F, Yakupoglu YK, Yilmaz AF, et al. Risk factors for systemic inflammatory response syndrome following percutaneous nephrolithotomy. Urolithiasis. 2013; 41:395–401.
crossref
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003; 29:530–8.
crossref
12. Wei W, Leng J, Shao H, Wang W. Diabetes, a risk factor for both infectious and major complications after percutaneous nephrolithotomy. Int J Clin Exp Med. 2015; 8:16620–6.
13. Draga RO, Kok ET, Sorel MR, Bosch RJ, Lock TM. Percutaneous nephrolithotomy: factors associated with fever after the first postoperative day and systemic inflammatory response syndrome. J Endourol. 2009; 23:921–7.
crossref
14. Korets R, Graversen JA, Kates M, Mues AC, Gupta M. Post-percutaneous nephrolithotomy systemic inflammatory response: a prospective analysis of preoperative urine, renal pelvic urine and stone cultures. J Urol. 2011; 186:1899–903.
crossref
15. Cetinkaya M, Buldu I, Kurt O, Inan R. Platelet-to-lymphocyte ratio: a new factor for predicting systemic inflammatory response syndrome after percutaneous nephrolithotomy. Urol J. 2017; 14:4089–93.
16. Sharifi Aghdas F, Akhavizadegan H, Aryanpoor A, Inanloo H, Karbakhsh M. Fever after percutaneous nephrolithotomy: contributing factors. Surg Infect (Larchmt). 2006; 7:367–71.
17. Yang T, Liu S, Hu J, Wang L, Jiang H. The evaluation of risk factors for postoperative infectious complications after percutaneous nephrolithotomy. Biomed Res Int. 2017; 2017:4832051.
crossref
18. Mariappan P, Smith G, Bariol SV, Moussa SA, Tolley DA. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study. J Urol. 2005; 173:1610–4.
crossref
19. Walton-Diaz A, Vinay JI, Barahona J, Daels P, Gonzalez M, Hidalgo JP, et al. Concordance of renal stone culture: PMUC, RPUC, RSC and post-PCNL sepsis-a non-randomized prospective observation cohort study. Int Urol Nephrol. 2017; 49:31–5.
crossref
20. Chew BH, Miller NL, Abbott JE, Lange D, Humphreys MR, Pais VM Jr, et al. A randomized controlled trial of preoperative prophylactic antibiotics prior to percutaneous nephrolithotomy in a low infectious risk population: a report from the EDGE consortium. J Urol. 2018; 200:801–8.
crossref
21. Singh I, Shah S, Gupta S, Singh NP. Efficacy of intraoperative renal stone culture in predicting postpercutaneous nephrolithotomy urosepsis/systemic inflammatory response syndrome: a prospective analytical study with review of literature. J Endourol. 2019; 33:84–92.
crossref
22. Rivera M, Viers B, Cockerill P, Agarwal D, Mehta R, Krambeck A. Pre-and postoperative predictors of infection-related complications in patients undergoing percutaneous nephrolithotomy. J Endourol. 2016; 30:982–6.
23. Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents. 2001; 17:287–92.
crossref
24. Gutierrez J, Smith A, Geavlete P, Shah H, Kural AR, de Sio M, et al. Urinary tract infections and postoperative fever in percutaneous nephrolithotomy. World J Urol. 2013; 31:1135–40.
crossref
25. Giubilato S, Liuzzo G, Brugaletta S, Pitocco D, Graziani F, Smaldone C, et al. Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J. 2011; 32:1214–26.
crossref
26. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013; 39:165–228.
crossref
27. Margel D, Ehrlich Y, Brown N, Lask D, Livne PM, Lifshitz DA. Clinical implication of routine stone culture in percutaneous nephrolithotomy–a prospective study. Urology. 2006; 67:26–9.
crossref
28. Patel N, Shi W, Liss M, Raheem O, Wenzler D, Schallhorn C, et al. Multidrug resistant bacteriuria before percutaneous nephrolithotomy predicts for postoperative infectious complications. J Endourol. 2015; 29:531–6.
crossref
29. Sen V, Bozkurt IH, Aydogdu O, Yonguc T, Yarimoglu S, Sen P, et al. Significance of preoperative neutrophil-lymphocyte count ratio on predicting postoperative sepsis after percutaneous nephrolithotomy. Kaohsiung J Med Sci. 2016; 32:507–13.
crossref
30. Ganesan V, Brown RD, Jimenez JA, De S, Monga M. C-reactive protein and erythrocyte sedimentation rate predict systemic inflammatory response syndrome after percutaneous nephrolithotomy. J Endourol. 2017; 31:638–44.
crossref
31. Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. BJU Int. 2006; 98:1075–9.
crossref
32. Omar M, Noble M, Sivalingam S, El Mahdy A, Gamal A, Farag M, et al. Systemic inflammatory response syndrome after percutaneous nephrolithotomy: a randomized single-blind clinical trial evaluating the impact of irrigation pressure. J Urol. 2016; 196:109–14.
crossref
33. Roushani A, Falahatkar S, Sharifi SH, Mahfoozi L, Saadat SM, Allahkhah A, et al. Intraoperative stone culture as an independent predictor of systemic inflammatory response syndrome after percutaneous nephrolithotomy. Urolithiasis. 2014; 42:455–9.
crossref
34. Lojanapiwat B, Kitirattrakarn P. Role of preoperative and intraoperative factors in mediating infection complication following percutaneous nephrolithotomy. Urol Int. 2011; 86:448–52.
crossref
35. Kreydin EI, Eisner BH. Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol. 2013; 10:598–605.
crossref
36. McAleer IM, Kaplan GW, Bradley JS, Carroll SF, Griffith DP. Endotoxin content in renal calculi. J Urol. 2003; 169:1813–4.
crossref
37. Degirmenci T, Bozkurt IH, Celik S, Yarimoglu S, Basmaci I, Sefik E. Does leaving residual fragments after percutaneous nephrolithotomy in patients with positive stone culture and/or renal pelvic urine culture increase the risk of infectious complications? Urolithiasis 2018 Jun 4 [Epub]. DOI: 10.1007/s00240-018-1063-9.
38. Ramaraju K, Paranjothi AK, Namperumalsamy DB, Chen-nakrishnan I. Predictors of systemic inflammatory response syndrome following percutaneous nephrolithotomy. Urol Ann. 2016; 8:449–53.
crossref
39. Shoshany O, Margel D, Finz C, Ben-Yehuda O, Livne PM, Holand R, et al. Percutaneous nephrolithotomy for infection stones: what is the risk for postoperative sepsis? A retrospective cohort study. Urolithiasis. 2015; 43:237–42.
crossref

Table 1.
Definitions of SIRS, infection, and sepsis
SIRS Two or more of the following:
‐ Body temperature >38°C or <36°C
‐ Heart rate>90 bpm
‐ Respiratory rate>20 breaths/min or PaCO2<32 mmHg
‐ White blood cell count >12,000 cells/μl or <4,000 cells/μl
Infection Pathological process caused by the invasion of normally sterile tissue or fluid or the body cavity by pathogenic or potentially pathogenic micro-organisms
Sepsis Clinical syndrome defined by the presence of both SIRS and infection
Severe sepsis Sepsis resulting in organ dysfunction
Septic shock Sepsis resulting in acute circulatory failure characterized by persistent arterial hypotension

SIRS: systemic inflammatory response syndrome, bpm: beats per minute.

Modified from the article of Levy et al. Intensive Care Med 2003;29:530–8 [11 ] with original copyright holder's permission.

TOOLS
Similar articles